Literature DB >> 16414245

Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia.

Nikola A Bowden1, Judith Weidenhofer, Rodney J Scott, Ulrich Schall, Juanita Todd, Patricia T Michie, Paul A Tooney.   

Abstract

Schizophrenia is a heterogenous disorder that is phenomenologically characterised by a combination of negative, positive, and cognitive symptoms with variable expression in the course of illness. Here, we investigated differential gene expression in relation to age to address the heterogeneity of this disorder We used 6000 gene cDNA microarrays to generate gene expression profiles from peripheral blood lymphocytes from 14 individuals with schizophrenia and 14 non-psychiatric controls. Genes showing altered expression were identified and 18 genes with brain-related functions were altered, 4 of which, endothelial differentiation gene 2 (Edg-2), ezrin-radixin-moesin phosphoprotein 50 (EBP50), Myc-associated zinc finger protein (MAZ) and Tumor Necrosis Factor Receptor 2 (TNFR2), were confirmed by relative real-time PCR. Dendrograms were constructed using genes that showed significantly different expression (p<0.05) between groups based on median split of age dividing the matched pairs into distinct subclasses. Our findings suggest that distinct gene expression profiles in peripheral blood lymphocytes associated with schizophrenia phenotypes may provide a first step towards the biological classification of schizophrenia subtypes. The validity of this approach may lead to better methods of defining this enigmatic disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16414245     DOI: 10.1016/j.schres.2005.11.012

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  41 in total

Review 1.  Gene expression in the etiology of schizophrenia.

Authors:  Nicholas J Bray
Journal:  Schizophr Bull       Date:  2008-03-11       Impact factor: 9.306

Review 2.  Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia?

Authors:  Henry Silver; Yael Chertkow; Orly Weinreb; Lena Danovich; Moussa Youdim
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

3.  Exon Array Biomarkers for the Differential Diagnosis of Schizophrenia and Bipolar Disorder.

Authors:  Marquis Philip Vawter; Robert Philibert; Brandi Rollins; Patricia L Ruppel; Terry W Osborn
Journal:  Mol Neuropsychiatry       Date:  2018-04-10

Review 4.  GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Authors:  Erik I Charych; Feng Liu; Stephen J Moss; Nicholas J Brandon
Journal:  Neuropharmacology       Date:  2009-07-23       Impact factor: 5.250

5.  Rare NRXN1 promoter variants in patients with schizophrenia.

Authors:  Abhishek K Shah; Nina M Tioleco; Karen Nolan; Joseph Locker; Katherine Groh; Catalina Villa; Pavla Stopkova; Erika Pedrosa; Herbert M Lachman
Journal:  Neurosci Lett       Date:  2010-03-25       Impact factor: 3.046

6.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

7.  Intelligence in Williams Syndrome is related to STX1A, which encodes a component of the presynaptic SNARE complex.

Authors:  Michael C Gao; Ursula Bellugi; Li Dai; Debra L Mills; Eric M Sobel; Kenneth Lange; Julie R Korenberg
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

8.  Gene expression profiling of xeroderma pigmentosum.

Authors:  Nikola A Bowden; Paul A Tooney; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857

Review 9.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

10.  Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10.

Authors:  So Young Lee; Juanma Ramirez; Maribel Franco; Benoît Lectez; Monika Gonzalez; Rosa Barrio; Ugo Mayor
Journal:  Cell Mol Life Sci       Date:  2013-12-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.